Literature DB >> 24475449

Serum amyloid A  renal amyloidosis in a chronic subcutaneous ("skin popping") heroin user.

Chad Cooper1, Jorge E Bilbao2, Sarmad Said1, Haider Alkhateeb1, Jorge Bizet1, Ahmed Elfar1, Olinamyr Davalos3, Ana T Meza3, German T Hernandez1.   

Abstract

BACKGROUND: Systemic AA amyloidosis is a long-term complication of several chronic inflammatory disorders. Organ damage results from the extracellular deposition of proteolytic fragments of the acute-phase reactant serum amyloid A (SAA) as amyloid fibrils. Drug users that inject drug by a subcutaneous route ("skin popping") have a higher chance of developing secondary amyloidosis. The kidneys, liver, and spleen are the main target organs of AA amyloid deposits. More than 90% of patients with renal amyloidosis will present with proteinuria, nephrotic syndrome, or renal function. CASE
PRESENTATION: A 37 year-old female presented to the hospital with a one-week history of pain and redness in her right axilla. Her relevant medical history included multiple skin abscesses secondary to "skin popping", heroin abuse for 18 years, and hepatitis C. The physical examination revealed "skin popping" lesions, bilateral costovertebral angle tenderness, and bilateral knee swelling. The laboratory workup was significant for renal insufficiency with a serum creatinine of 5 mg/dL and 14.8 grams of urine protein per 1 gram of urine creatinine. The renal biopsy findings were consistent with a diagnosis of renal amyloidosis due to serum amyloid A deposition and acute tubulointerstitial nephritis.
CONCLUSIONS: AA renal amyloidosis among heroin addicts seems to be associated with chronic suppurative skin infection secondary to "skin popping". It is postulated that the chronic immunologic stimulation by one or more exogenous antigens or multiple acute inflammatory episodes is an important factor in the pathogenesis of amyloidosis in these patients. Therefore, AA renal amyloidosis should always be considered in chronic heroin users presenting with proteinuria and renal impairment.

Entities:  

Keywords:  Acute tubulointerstitial nephritis; Heroin; Renal amyloidosis; Skin popping

Year:  2013        PMID: 24475449      PMCID: PMC3891138          DOI: 10.12860/JNP.2013.31

Source DB:  PubMed          Journal:  J Nephropathol        ISSN: 2251-8363


  10 in total

Review 1.  Amyloidosis-associated kidney disease.

Authors:  Laura M Dember
Journal:  J Am Soc Nephrol       Date:  2006-11-08       Impact factor: 10.121

Review 2.  Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts).

Authors:  G G Glenner
Journal:  N Engl J Med       Date:  1980-06-05       Impact factor: 91.245

Review 3.  AA amyloidosis: basic knowledge, unmet needs and future treatments.

Authors:  Laura Obici; Giampaolo Merlini
Journal:  Swiss Med Wkly       Date:  2012-05-31       Impact factor: 2.193

4.  Amyloidosis in subcutaneous heroin abusers ("skin poppers' amyloidosis").

Authors:  J Neugarten; G R Gallo; J Buxbaum; L A Katz; J Rubenstein; D S Baldwin
Journal:  Am J Med       Date:  1986-10       Impact factor: 4.965

5.  Renal amyloidosis in intravenous heroin addicts with nephrotic syndrome and renal failure.

Authors:  I Manner; S Sagedal; M Røger; I Os
Journal:  Clin Nephrol       Date:  2009-09       Impact factor: 0.975

6.  Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis.

Authors:  Rosemary O'Hara; Evelyn P Murphy; Alexander S Whitehead; Oliver FitzGerald; Barry Bresnihan
Journal:  Arthritis Rheum       Date:  2004-06

7.  Amyloidosis in chronic heroin addicts with the nephrotic syndrome.

Authors:  J Scholes; R Derosena; G B Appel; W Jao; M T Boyd; C L Pirani
Journal:  Ann Intern Med       Date:  1979-07       Impact factor: 25.391

8.  Renal amyloidosis in a drug abuser.

Authors:  A U Tan; A H Cohen; B S Levine
Journal:  J Am Soc Nephrol       Date:  1995-03       Impact factor: 10.121

9.  Renal amyloidosis in intravenous drug users.

Authors:  J O Connolly; J D Gillmore; H J Lachmann; A Davenport; P N Hawkins; R G Woolfson
Journal:  QJM       Date:  2006-09-06

10.  Natural history and outcome in systemic AA amyloidosis.

Authors:  Helen J Lachmann; Hugh J B Goodman; Janet A Gilbertson; J Ruth Gallimore; Caroline A Sabin; Julian D Gillmore; Philip N Hawkins
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

  10 in total
  4 in total

1.  Amyloid A amyloidosis: frequently neglected renal disease in injecting drug users.

Authors:  Ali Nayer
Journal:  J Nephropathol       Date:  2013-08-01

2.  Amyloid A amyloidosis with subcutaneous drug abuse.

Authors:  Jair Munoz Mendoza; Vasil Peev; Mario A Ponce; David B Thomas; Ali Nayer
Journal:  J Renal Inj Prev       Date:  2013-11-02

Review 3.  Systematic review of nephrotoxicity of drugs of abuse, 2005-2016.

Authors:  Kanaan Mansoor; Murad Kheetan; Saba Shahnawaz; Anna P Shapiro; Eva Patton-Tackett; Larry Dial; Gary Rankin; Prasanna Santhanam; Antonios H Tzamaloukas; Tibor Nadasdy; Joseph I Shapiro; Zeid J Khitan
Journal:  BMC Nephrol       Date:  2017-12-29       Impact factor: 2.388

4.  Recognizing Skin Popping Scars: A Complication of Illicit Drug Use.

Authors:  Rachael C Saporito; Mildred A Lopez Pineiro; Micheal R Migden; Sirunya Silapunt
Journal:  Cureus       Date:  2018-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.